期刊文献+

糖原合成酶激酶-3β与心血管疾病 被引量:1

下载PDF
导出
摘要 糖原合成酶激酶-3β(GSK-3β)是一种丝氨酸/苏氨酸蛋白激酶,大量的实验研究证明GSK-3β与缺血-再灌注损伤密切相关,缺血预处理、后处理及许多心肌保护药物被认为都是通过调节GSK-3β来发挥他们的心肌保护作用,而且GSK-3β被认为是一个心肌肥大的负调节因子。鉴于GSK-3β与心血管疾病的密切相关性。该文将GSK-3β在缺血-再灌注损伤及心肌肥大中的作用及其机制作一综述。
出处 《国际心血管病杂志》 2010年第1期24-26,共3页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献18

  • 1Liao R, Force T. Not all hypertrophy is created equal[J]. Cire Res, 2007, 101(11) : 1069 -1072.
  • 2Doble BW, Woodgett JR. GSK 3: tricks of the trade for a multi tasking kinase[J].J Cell Sci, 2003, 116 (Pt 7): 1175-1186.
  • 3Kerkela R, Woulfe K, Force T. Glycogen synthase kinase- 3beta-actively inhibiting hypertrophy [J]. Trends Cardiovasc Med, 2007, 17(3): 91- 96.
  • 4Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative larger for cardioprotection [J]. Cell Physiol Biochem, 2007, 20(1-4) : 1-22.
  • 5Juhaszova M, Zorov DB, Kim SH, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore [J].J Clin Invest, 2004, 113(11): 1535-1549.
  • 6Das S, Wong R, Rajapakse N, et al. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation[J]. Cire Res, 2008, 103(9): 983- 991.
  • 7Gustafsson AB, Gottlieb RA. Heart mitochondria: gates of life and death[J]. Cardiovasc Res, 2008, 77(2): 334-343.
  • 8Juhaszova M, Wang S, Zorov DB, et al. The identity and regulation of the mitoehondrial permeability transition pore: where the known meets the unknown[J]. Ann N Y Aead Sci, 2008, 1123:197- 212.
  • 9Zhai P, Sadoshima J. Overcoming an energy crisis?: an adap rive role of glycogen synthase kinase-3 inhibition in ischemial reperfusion[J]. CircRes, 2008, 103(9): 910 -913.
  • 10Freeman RS, Barone MC. Targeting hypoxia-indueible factor (HIF) as a therapeutic strategy for CNS disorders[J]. Curr Drug Targets CNS Neurol Disord, 2(t05, 4( 1 ) : 85-92.

同被引文献12

  • 1Srivastava G,Mehta JL. Currying the heart:curcumin and cardioprotection[J].Journal of Cardiovascular Pharmacology and therapeutics,2009,(01):22-27.
  • 2Chanoit G,Lee S,Xi J. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase3beta[J].American Journal of Physiology-Heart and Circulatory Physiology,2008,(03):H1227-H1233.
  • 3Zhou H,Beevers CS,Huang S. The targets of curcumin[J].Current Drug Targets,2011,(03):332-347.
  • 4Forde JE,Dale TC. Glycogen synthase kinase 3:a key regulator of cellular fate[J].Cellular and Molecular Life Sciences,2007,(15):1930-1944.doi:10.1007/s00018-007-7045-7.
  • 5Jope RS,Johnson GV. The glamour and gloom of glycogen synthase kinase-3[J].Trends in Biochemical Sciences,2004,(02):95-102.doi:10.1016/j.tibs.2003.12.004.
  • 6Vasileva AK,Plotnikov EY,Kazachenko AV. Inhibition of GSK-3β decreases the ischemiainduced death of renal cells[J].Bulletin of Experimental Biology and Medicine,2010,(03):303-307.
  • 7Cuzzocrea S,Mazzon E,Esposito E. Glycogen synthase kinase-3beta inhibition attenuates the development of ischemia/reperfusion injury of the gut[J].Intensive Care Medicine,2007,(05):880-893.doi:10.1007/s00134-007-0595-1.
  • 8Collino M,Thiemermann C,Mastrocola R. Treatment with the glycogen synthase kinase3beta inhibitor,TDZD-8,affects transient cerebral ischemia/reperfusion injury in the rat hippocampus[J].Shock,2008,(03):299-307.doi:10.1097/SHK.0b013e318164e762.
  • 9Gao HK,Yin Z,Zhou N. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis[J].Journal of Cardiovascular Pharmacology and therapeutics,2008,(03):286-292.
  • 10Zhai P,Sciarretta S,Galeotti J. Differential roles of GSK-3β during myocardial ischemia and ischemia/reperfusion[J].Circulation Research,2011,(05):502-511.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部